Handelsbanken Fonder AB Has $1.64 Million Stock Holdings in Bruker Co. (NASDAQ:BRKR)

Handelsbanken Fonder AB lowered its position in shares of Bruker Co. (NASDAQ:BRKR - Free Report) by 92.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 28,000 shares of the medical research company's stock after selling 340,000 shares during the quarter. Handelsbanken Fonder AB's holdings in Bruker were worth $1,641,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in the company. True Wealth Design LLC grew its position in Bruker by 4,636.4% during the third quarter. True Wealth Design LLC now owns 521 shares of the medical research company's stock valued at $36,000 after purchasing an additional 510 shares in the last quarter. Eagle Bay Advisors LLC grew its position in Bruker by 2,324.1% during the fourth quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company's stock valued at $41,000 after purchasing an additional 674 shares in the last quarter. UMB Bank n.a. grew its position in Bruker by 37.5% during the fourth quarter. UMB Bank n.a. now owns 909 shares of the medical research company's stock valued at $53,000 after purchasing an additional 248 shares in the last quarter. GAMMA Investing LLC grew its position in Bruker by 47.5% during the fourth quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company's stock valued at $75,000 after purchasing an additional 412 shares in the last quarter. Finally, Capital Performance Advisors LLP purchased a new position in Bruker during the third quarter valued at approximately $77,000. Institutional investors and hedge funds own 79.52% of the company's stock.

Remove Ads

Analyst Ratings Changes

Several analysts have commented on the stock. Guggenheim reissued a "buy" rating on shares of Bruker in a research report on Monday, February 24th. UBS Group assumed coverage on shares of Bruker in a research report on Tuesday, December 10th. They issued a "neutral" rating and a $66.00 target price for the company. Stifel Nicolaus decreased their target price on shares of Bruker from $70.00 to $57.00 and set a "hold" rating for the company in a research report on Friday, February 14th. TD Cowen decreased their target price on shares of Bruker from $72.00 to $70.00 and set a "hold" rating for the company in a research report on Wednesday, November 6th. Finally, Barclays decreased their target price on shares of Bruker from $69.00 to $65.00 and set an "overweight" rating for the company in a research report on Monday, February 10th. Six investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $70.50.

Bruker Stock Performance

Shares of NASDAQ BRKR traded down $0.54 during trading hours on Friday, hitting $47.22. 1,924,165 shares of the stock were exchanged, compared to its average volume of 1,656,143. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.60 and a quick ratio of 0.77. The company's 50 day moving average is $56.24 and its 200 day moving average is $59.72. The firm has a market capitalization of $7.16 billion, a P/E ratio of 62.13, a P/E/G ratio of 2.16 and a beta of 1.16. Bruker Co. has a one year low of $46.41 and a one year high of $94.86.

Bruker (NASDAQ:BRKR - Get Free Report) last posted its quarterly earnings data on Thursday, February 13th. The medical research company reported $0.76 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.75 by $0.01. Bruker had a net margin of 3.36% and a return on equity of 21.01%. On average, research analysts expect that Bruker Co. will post 2.69 EPS for the current year.

Bruker Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, March 28th. Investors of record on Monday, March 17th will be paid a dividend of $0.05 per share. This represents a $0.20 annualized dividend and a yield of 0.42%. The ex-dividend date of this dividend is Monday, March 17th. Bruker's payout ratio is currently 26.32%.

Bruker Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.